CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 250 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $793,088 | +103032.4% | 51,200 | +6.0% | 0.00% | 0.0% |
Q1 2024 | $769 | -18.5% | 48,300 | -13.9% | 0.00% | -25.0% |
Q4 2023 | $943 | +36.3% | 56,100 | -5.2% | 0.00% | +33.3% |
Q3 2023 | $692 | -13.0% | 59,200 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $795 | -69.4% | 59,200 | -62.3% | 0.00% | -25.0% |
Q1 2023 | $2,601 | +187.4% | 156,900 | +222.2% | 0.00% | 0.0% |
Q4 2022 | $905 | -99.9% | 48,700 | -22.0% | 0.00% | 0.0% |
Q3 2022 | $800,000 | +11.4% | 62,400 | -39.1% | 0.00% | +33.3% |
Q2 2022 | $718,000 | -17.2% | 102,500 | -2.1% | 0.00% | 0.0% |
Q1 2022 | $867,000 | +1.0% | 104,700 | -17.4% | 0.00% | 0.0% |
Q4 2021 | $858,000 | +1.2% | 126,800 | -20.8% | 0.00% | 0.0% |
Q3 2021 | $848,000 | +2.8% | 160,000 | +11.5% | 0.00% | 0.0% |
Q2 2021 | $825,000 | -8.1% | 143,500 | -26.3% | 0.00% | 0.0% |
Q1 2021 | $898,000 | +49.7% | 194,800 | +8.3% | 0.00% | +50.0% |
Q4 2020 | $600,000 | +20.5% | 179,800 | +7.2% | 0.00% | 0.0% |
Q3 2020 | $498,000 | -11.7% | 167,700 | +37.3% | 0.00% | 0.0% |
Q2 2020 | $564,000 | -1.7% | 122,100 | -18.1% | 0.00% | -33.3% |
Q1 2020 | $574,000 | +2.7% | 149,100 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $559,000 | -56.1% | 149,100 | -37.8% | 0.00% | -33.3% |
Q3 2019 | $1,272,000 | +96.6% | 239,800 | +42.3% | 0.00% | 0.0% |
Q2 2019 | $647,000 | -33.4% | 168,500 | -11.6% | 0.00% | -25.0% |
Q1 2019 | $972,000 | +166.3% | 190,600 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $365,000 | -49.3% | 190,600 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $720,000 | +3.4% | 190,600 | -14.6% | 0.00% | 0.0% |
Q2 2018 | $696,000 | +30.6% | 223,100 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $533,000 | -16.3% | 223,100 | +36.9% | 0.00% | -33.3% |
Q4 2017 | $637,000 | +2175.0% | 163,000 | +576.3% | 0.00% | – |
Q1 2016 | $28,000 | -52.5% | 24,100 | 0.0% | 0.00% | – |
Q4 2015 | $59,000 | -18.1% | 24,100 | 0.0% | 0.00% | – |
Q3 2015 | $72,000 | -27.3% | 24,100 | 0.0% | 0.00% | – |
Q2 2015 | $99,000 | – | 24,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |